scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YEXCR.2014.01.031 |
P8608 | Fatcat ID | release_kn4ajdqjafh2tgwsurzc467q44 |
P698 | PubMed publication ID | 24569142 |
P50 | author | Fabian Benencia | Q55071808 |
P2093 | author name string | Maria Muccioli | |
Yihan Li | |||
Alexander Ostermann | |||
Yandi Li | |||
Leslee Sprague | |||
Maria Cecilia Courreges | |||
Michelle Pate | |||
Manindra Singh | |||
Brandon Niese | |||
Chengkai Xiong | |||
P2860 | cites work | The Hallmarks of Cancer | Q221226 |
Induction of dendritic cell-like phenotype in macrophages during foam cell formation | Q24294246 | ||
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
The biology of VEGF and its receptors | Q27860704 | ||
Mammalian collagen IV | Q28265884 | ||
Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury | Q28286412 | ||
Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties | Q28300388 | ||
Immunobiology of dendritic cells | Q29547465 | ||
Differential antigen processing by dendritic cell subsets in vivo | Q29615177 | ||
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors | Q29618425 | ||
Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent | Q30440410 | ||
In vitro model of atherosclerosis using coculture of arterial wall cells and macrophage | Q30980879 | ||
Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease | Q33276712 | ||
TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype | Q33323527 | ||
Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation | Q74420456 | ||
Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? | Q74675085 | ||
Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF | Q74817245 | ||
THE INFLUENCE OF AGE AND ATHEROSCLEROSIS ON THE CHEMISTRY OF AORTIC INTIMA.2. COLLAGEN AND MUCOPOLYSACCHARIDES | Q78283068 | ||
Dendritic cells in the arterial wall express C1q: potential significance in atherogenesis | Q79106760 | ||
Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking | Q79912711 | ||
CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden | Q80198007 | ||
Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression | Q80352278 | ||
Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer | Q80458732 | ||
Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A | Q80501633 | ||
Vascular leukocytes contribute to tumor vascularization | Q80546906 | ||
Subpopulations of human dendritic cells display a distinct phenotype and bind differentially to proteins of the extracellular matrix | Q80775172 | ||
Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques | Q81802868 | ||
Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma | Q81859838 | ||
Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice | Q82080491 | ||
Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice | Q83630548 | ||
Dendritic cells treated with HPV16mE7 in a three-dimensional model promote the secretion of IL-12p70 and IFN-γ | Q83778695 | ||
Inhibition of tumor growth by peptide specific cytotoxic T lymphocytes in a three-dimensional collagen matrix | Q73006739 | ||
Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells | Q73969253 | ||
Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells | Q33890964 | ||
Collagens and atherosclerosis | Q33922257 | ||
The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells. | Q33924531 | ||
RhoA-dependent switch between alpha2beta1 and alpha3beta1 integrins is induced by laminin-5 during early stage of HT-29 cell differentiation | Q33948290 | ||
Dendritic cells and their involvement in atherosclerosis | Q34069113 | ||
Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin | Q34103283 | ||
Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment | Q34183719 | ||
Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. | Q34251293 | ||
The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics | Q34282306 | ||
Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions | Q34457373 | ||
Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways | Q34482227 | ||
Vascular endothelial growth factor: basic science and clinical progress | Q34549887 | ||
Mammalian collagen receptors | Q34586505 | ||
Steady-state and inflammatory dendritic-cell development | Q34591334 | ||
Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. | Q35024786 | ||
Endothelial progenitor cell biology in disease and tissue regeneration | Q35069503 | ||
Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. | Q35088170 | ||
OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice | Q35187075 | ||
Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance | Q35217525 | ||
Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies | Q35221807 | ||
Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. | Q35748149 | ||
Dendritic cells in atherosclerosis: current status of the problem and clinical relevance | Q36108241 | ||
Adhesion to substrates induces dendritic cell endothelization and decreases immunological response. | Q36146867 | ||
VEGF as a therapeutic target in cancer | Q36319029 | ||
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody | Q36376567 | ||
Generation, migration and function of circulating dendritic cells | Q36507785 | ||
Potential role of dendritic cells for progression of atherosclerotic lesions | Q36586196 | ||
Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer | Q36693519 | ||
DC-based cancer vaccines | Q36809780 | ||
The role of the chemokines MCP-1, GRO-alpha, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques | Q36940248 | ||
The inhibitory collagen receptor LAIR-1 (CD305). | Q37026485 | ||
Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses | Q37156409 | ||
Notch signaling regulates tumor angiogenesis by diverse mechanisms | Q37256455 | ||
T-cell activation molecule 4-1BB binds to extracellular matrix proteins | Q37277146 | ||
2D and 3D collagen and fibrin biopolymers promote specific ECM and integrin gene expression by vascular smooth muscle cells | Q37318158 | ||
Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. | Q37342848 | ||
The paracrine role of Tie-2-expressing monocytes in tumor angiogenesis | Q37383349 | ||
The CD8+ dendritic cell subset | Q37700814 | ||
Origin and development of dendritic cells | Q37700819 | ||
Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation | Q37700828 | ||
TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure | Q37771751 | ||
Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination | Q38002844 | ||
Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues | Q38819807 | ||
Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential | Q39549098 | ||
In situ regulation of DC subsets and T cells mediates tumor regression in mice | Q39885761 | ||
A novel 3D in vitro culture model to study stromal-epithelial interactions in the mammary gland | Q39951860 | ||
Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation. | Q40060440 | ||
TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis | Q40337625 | ||
Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells | Q40564506 | ||
OxLDL upregulates CXCR2 expression in monocytes via scavenger receptors and activation of p38 mitogen-activated protein kinase | Q40752820 | ||
Development of a syngeneic mouse model for events related to ovarian cancer | Q40888613 | ||
Cxc chemokine receptor expression on human endothelial cells | Q40930195 | ||
Characterization of the migration of lung and blood T cells in response CXCL12 in a three-dimensional matrix | Q42152773 | ||
Cytokine and chemokine dynamics differ between rats and mice after collagen implantation | Q42521826 | ||
Synergic effects of crypt-like topography and ECM proteins on intestinal cell behavior in collagen based membranes. | Q42965579 | ||
Thrombospondin-1: a proatherosclerotic protein augmented by hyperglycemia | Q43124806 | ||
Three-dimensional collagen matrices as cell culture substrata affect the generation of alloreactive cytotoxic T lymphocytes | Q44222004 | ||
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection | Q44308127 | ||
HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer | Q44499920 | ||
Production and in vivo effects of chemokines CXCL1-3/KC and CCL2/JE in a model of inflammatory angiogenesis in mice. | Q45186058 | ||
Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis | Q46622055 | ||
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. | Q46664069 | ||
Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy | Q46706150 | ||
Murine chemokine CXCL2/KC is a surrogate marker for angiogenic activity in the inflammatory granulation tissue | Q46738102 | ||
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. | Q47810108 | ||
Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions | Q47863833 | ||
Influence of extracellular matrix proteins on the development of cultured human dendritic cells | Q48035769 | ||
A common pathway for dendritic cell and early B cell development. | Q51064515 | ||
Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. | Q51737378 | ||
CXCR4+/FLK-1+ biomarkers select a cardiopoietic lineage from embryonic stem cells. | Q51961075 | ||
The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation. | Q53329394 | ||
Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. | Q54001580 | ||
Implication of discoidin domain receptor 1 in T cell migration in three-dimensional collagen. | Q54434477 | ||
Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen. | Q54628562 | ||
The role of collagen receptors Endo180 and DDR-2 in the foreign body reaction against non-crosslinked collagen and gelatin. | Q54633485 | ||
Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas | Q58212133 | ||
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells | Q71607047 | ||
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree | Q72689998 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
atherosclerosis | Q12252367 | ||
P304 | page(s) | 7-27 | |
P577 | publication date | 2014-02-22 | |
P1433 | published in | Experimental Cell Research | Q1524289 |
P1476 | title | Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments | |
P478 | volume | 323 |
Search more.